How pharmaceutical leaders at established companies can still disrupt the status quo and change the game.
D. Scott Harper, PhD
Advertisement
Senior Partner, Business Advancement Inc. (BAI)
Articles by D. Scott Harper, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Johnson and Johnson’s Darzalex Faspro for Adults with High-Risk Smoldering Multiple Myeloma
2
Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1s to TrumpRX
3
In Obesity Care, NPs and PAs Are the Influencers Marketers Can’t Ignore
4
FDA Continues to Expand National Priority Voucher Program
5
